| Nicole Tong, PT,DPT | |
|
801 Merrick Ave, East Meadow, NY 11554-4748 | |
| (516) 393-8900 | |
| Not Available |
| Full Name | Nicole Tong |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 801 Merrick Ave, East Meadow, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033716808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 046369-1 (New York) | Primary |
| Provider Name | Sports Physical Therapy Occupational Therapy And Rehabilitation Servic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770540593 PECOS PAC ID: 0446140446 Enrollment ID: O20040315001603 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Researchers believe they have found a way to change the action of 60 percent of currently available medications, in some cases making them many times more effective, according to an article published in the April 21 edition of the journal Science. The discovery has the potential to improve treatments for diseases including heart disease, cancer, diabetes, depression and arthritis. The study describes a new way to manipulate perhaps the most important signaling mechanism in human cells: G-protein coupled receptors (GPCRs).
Today, the Chan Zuckerberg Initiative announced $14 million in funding to support 29 interdisciplinary teams and build a network of researchers that will explore emerging ideas regarding the role of inflammation in disease.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that its new oral anticoagulant, Pradaxa® (dabigatran etexilate mesylate) 150mg capsules, will be available starting Wednesday by prescription in pharmacies across the United States, including CVS/pharmacy, Rite Aid, Walmart, Target, Kmart® and The Kroger Co. In addition, leading independents under the Health Mart®, Good Neighbor Pharmacy® and Medicine Shoppe® banners will be stocked.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Tong, PT,DPT 1983 Marcus Ave, New Hyde Park, NY 11042-2000 Ph: (516) 321-7526 | Nicole Tong, PT,DPT 801 Merrick Ave, East Meadow, NY 11554-4748 Ph: (516) 393-8900 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Researchers believe they have found a way to change the action of 60 percent of currently available medications, in some cases making them many times more effective, according to an article published in the April 21 edition of the journal Science. The discovery has the potential to improve treatments for diseases including heart disease, cancer, diabetes, depression and arthritis. The study describes a new way to manipulate perhaps the most important signaling mechanism in human cells: G-protein coupled receptors (GPCRs).
Today, the Chan Zuckerberg Initiative announced $14 million in funding to support 29 interdisciplinary teams and build a network of researchers that will explore emerging ideas regarding the role of inflammation in disease.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that its new oral anticoagulant, Pradaxa® (dabigatran etexilate mesylate) 150mg capsules, will be available starting Wednesday by prescription in pharmacies across the United States, including CVS/pharmacy, Rite Aid, Walmart, Target, Kmart® and The Kroger Co. In addition, leading independents under the Health Mart®, Good Neighbor Pharmacy® and Medicine Shoppe® banners will be stocked.
› Verified 8 days ago
Gerigymllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 2147 4th St, East Meadow, NY 11554 Phone: 516-445-4935 | |
Robert Dimonte, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8900 | |
Thomas Maguffin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8900 | |
Laura A Richardson, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8900 | |
Donald J Rourke, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8900 Fax: 516-393-8969 | |
Sloan Yoselowitz, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2201 Hempstead Tpke, Nassau University Medical Center, East Meadow, NY 11554 Phone: 516-572-6131 |